72 related articles for article (PubMed ID: 19494059)
1. Nosocomial outbreak of a non-cefepime-susceptible ceftazidime-susceptible Pseudomonas aeruginosa strain overexpressing MexXY-OprM and producing an integron-borne PSE-1 betta-lactamase.
Peña C; Suarez C; Tubau F; Juan C; Moya B; Dominguez MA; Oliver A; Pujol M; Ariza J
J Clin Microbiol; 2009 Aug; 47(8):2381-7. PubMed ID: 19494059
[TBL] [Abstract][Full Text] [Related]
2. Treatment Outcomes for Carbapenem-Resistant and Cephalosporin-Susceptible
Ng TH; Zhao JJ; Gumbleton R; Olson S; Smith S; Scipione MR
Ann Pharmacother; 2024 Jun; 58(6):581-588. PubMed ID: 37752788
[TBL] [Abstract][Full Text] [Related]
3. Outbreak of Pseudomonas aeruginosa producing VIM carbapenemase in an intensive care unit and its termination by implementation of waterless patient care.
Catho G; Martischang R; Boroli F; Chraïti MN; Martin Y; Koyluk Tomsuk Z; Renzi G; Schrenzel J; Pugin J; Nordmann P; Blanc DS; Harbarth S
Crit Care; 2021 Aug; 25(1):301. PubMed ID: 34412676
[TBL] [Abstract][Full Text] [Related]
4. A synthetic peptide sensitizes multi-drug resistant Pseudomonas aeruginosa to antibiotics for more than two hours and permeabilizes its envelope for twenty hours.
Rázquin-Olazarán I; Shahrour H; Martínez-de-Tejada G
J Biomed Sci; 2020 Aug; 27(1):85. PubMed ID: 32762680
[TBL] [Abstract][Full Text] [Related]
5. Comparative Efficacy of Continuous Ceftazidime Infusion vs. Intermittent Bolus against In Vitro Ceftazidime-Susceptible and -Resistant
El Haj C; Agustí E; Benavent E; Soldevila-Boixader L; Rigo-Bonnin R; Tubau F; Torrejón B; Esteban J; Murillo O
Antibiotics (Basel); 2024 Apr; 13(4):. PubMed ID: 38667020
[No Abstract] [Full Text] [Related]
6. A fractional-order model for nosocomial infection caused by Pseudomonas aeruginosa in Northern Cyprus.
Bagkur C; Amilo D; Kaymakamzade B
Comput Biol Med; 2024 Mar; 171():108094. PubMed ID: 38335823
[TBL] [Abstract][Full Text] [Related]
7. Detection of Temporal Clusters of Healthcare-Associated Infections or Colonizations with Pseudomonas aeruginosa in Two Hospitals: Comparison of SaTScan and WHONET Software Packages.
Lefebvre A; Bertrand X; Vanhems P; Lucet JC; Chavanet P; Astruc K; Thouverez M; Quantin C; Aho-Glélé LS
PLoS One; 2015; 10(10):e0139920. PubMed ID: 26448036
[TBL] [Abstract][Full Text] [Related]
8. Prolonged outbreak of clonal MDR
Salm F; Deja M; Gastmeier P; Kola A; Hansen S; Behnke M; Gruhl D; Leistner R
Antimicrob Resist Infect Control; 2016; 5():53. PubMed ID: 27980730
[TBL] [Abstract][Full Text] [Related]
9.
Baudet A; Regad M; Gibot S; Conrath É; Lizon J; Demoré B; Florentin A
Antibiotics (Basel); 2024 Apr; 13(5):. PubMed ID: 38786119
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial.
Pericàs JM; Moreno A; Almela M; García-de-la-Mària C; Marco F; Muñoz P; Peña C; de Alarcón A; Del Río A; Eworo A; Cruceta A; Paré JC; Mestres CA; Miró JM;
Clin Microbiol Infect; 2018 Jun; 24(6):673-676. PubMed ID: 29408610
[No Abstract] [Full Text] [Related]
11. Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection.
Suárez C; Peña C; Gavaldà L; Tubau F; Manzur A; Dominguez MA; Pujol M; Gudiol F; Ariza J
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e73-8. PubMed ID: 20223693
[TBL] [Abstract][Full Text] [Related]
12. It's Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-Resistant
Behzadi P; Baráth Z; Gajdács M
Antibiotics (Basel); 2021 Jan; 10(1):. PubMed ID: 33406652
[No Abstract] [Full Text] [Related]
13. Molecular Epidemiology of Multi-Drug Resistant
Pappa O; Kefala AM; Tryfinopoulou K; Dimitriou M; Kostoulas K; Dioli C; Moraitou E; Panopoulou M; Vogiatzakis E; Mavridou A; Galanis A; Beloukas A
Microorganisms; 2020 Oct; 8(11):. PubMed ID: 33114400
[TBL] [Abstract][Full Text] [Related]
14. Diverse Genetic Background of Multidrug-Resistant Pseudomonas aeruginosa from Mainland China, and Emergence of an Extensively Drug-Resistant ST292 Clone in Kunming.
Fan X; Wu Y; Xiao M; Xu ZP; Kudinha T; Bazaj A; Kong F; Xu YC
Sci Rep; 2016 May; 6():26522. PubMed ID: 27198004
[TBL] [Abstract][Full Text] [Related]
15. High-Resolution Analysis by Whole-Genome Sequencing of an International Lineage (Sequence Type 111) of Pseudomonas aeruginosa Associated with Metallo-Carbapenemases in the United Kingdom.
Turton JF; Wright L; Underwood A; Witney AA; Chan YT; Al-Shahib A; Arnold C; Doumith M; Patel B; Planche TD; Green J; Holliman R; Woodford N
J Clin Microbiol; 2015 Aug; 53(8):2622-31. PubMed ID: 26041902
[TBL] [Abstract][Full Text] [Related]
16. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.
Li XZ; Plésiat P; Nikaido H
Clin Microbiol Rev; 2015 Apr; 28(2):337-418. PubMed ID: 25788514
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic pressure is a major risk factor for rectal colonization by multidrug-resistant Pseudomonas aeruginosa in critically ill patients.
Gómez-Zorrilla S; Camoez M; Tubau F; Periche E; Cañizares R; Dominguez MA; Ariza J; Peña C
Antimicrob Agents Chemother; 2014 Oct; 58(10):5863-70. PubMed ID: 25049255
[TBL] [Abstract][Full Text] [Related]
18. MexXY multidrug efflux system of Pseudomonas aeruginosa.
Morita Y; Tomida J; Kawamura Y
Front Microbiol; 2012; 3():408. PubMed ID: 23233851
[TBL] [Abstract][Full Text] [Related]
19. Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients.
Peña C; Gómez-Zorrilla S; Suarez C; Dominguez MA; Tubau F; Arch O; Oliver A; Pujol M; Ariza J
Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2791-7. PubMed ID: 22552893
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
